Power priors based on multiple historical studies for binary outcomes
暂无分享,去创建一个
[1] Leonhard Held,et al. Adaptive power priors with empirical Bayes for clinical trials , 2017, Pharmaceutical statistics.
[2] Yuyan Duan,et al. A Modified Bayesian Power Prior Approach with Applications in Water Quality Evaluation , 2005 .
[3] Heinz Schmidli,et al. On the Use of Co-Data in Clinical Trials , 2016 .
[4] Joseph G Ibrahim,et al. The power prior: theory and applications , 2015, Statistics in medicine.
[5] Marc Vandemeulebroecke,et al. Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial , 2012, Gut.
[6] James O. Berger,et al. Rejection odds and rejection ratios: A proposal for statistical practice in testing hypotheses , 2015, Journal of mathematical psychology.
[7] A. Dawid. The Well-Calibrated Bayesian , 1982 .
[8] James O. Berger,et al. The interplay of Bayesian and frequentist analysis , 2004 .
[9] Adrian F. M. Smith,et al. Sampling-Based Approaches to Calculating Marginal Densities , 1990 .
[10] D. Spiegelhalter,et al. Summarizing historical information on controls in clinical trials , 2010, Clinical trials.
[11] J. Ibrahim,et al. Power prior distributions for regression models , 2000 .
[12] Joseph G. Ibrahim,et al. The relationship between the power prior and hierarchical models , 2006 .
[13] R. Cuffe. The inclusion of historical control data may reduce the power of a confirmatory study , 2011, Statistics in medicine.
[14] J. Ramirez,et al. Randomized Phase 2 Trial To Evaluate the Clinical Efficacy of Two High-Dosage Tigecycline Regimens versus Imipenem-Cilastatin for Treatment of Hospital-Acquired Pneumonia , 2013, Antimicrobial Agents and Chemotherapy.
[15] D. Rubin. Bayesianly Justifiable and Relevant Frequency Calculations for the Applied Statistician , 1984 .
[16] M. Kieser,et al. Blinded sample size recalculation in clinical trials incorporating historical data. , 2017, Contemporary clinical trials.
[17] Anthony O'Hagan,et al. Robust meta‐analytic‐predictive priors in clinical trials with historical control information , 2014, Biometrics.
[18] Yvette van Norden,et al. Including historical data in the analysis of clinical trials: Is it worth the effort? , 2017, Statistical methods in medical research.
[19] Michael Branson,et al. A note on the power prior , 2009, Statistics in medicine.
[20] Andrew P Grieve,et al. Idle thoughts of a ‘well‐calibrated’ Bayesian in clinical drug development , 2016, Pharmaceutical statistics.
[21] S J Pocock,et al. The combination of randomized and historical controls in clinical trials. , 1976, Journal of chronic diseases.
[22] Keying Ye,et al. Evaluating water quality using power priors to incorporate historical information , 2006 .
[23] Rosalind Walley,et al. Addressing potential prior‐data conflict when using informative priors in proof‐of‐concept studies , 2017, Pharmaceutical statistics.
[24] Désirée van der Heijde,et al. Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial , 2013, The Lancet.
[25] D. Spiegelhalter,et al. Disease Mapping With WinBUGS and MLwiN, Bayesian Approaches to Clinical Trials and Health Care Evaluation , 2004 .
[26] M. V. van Driel,et al. Antibiotics for ventilator-associated pneumonia. , 2016, The Cochrane database of systematic reviews.
[27] Fang Chen,et al. Use of historical control data for assessing treatment effects in clinical trials , 2014, Pharmaceutical statistics.
[28] H. Joe. Dependence Modeling with Copulas , 2014 .